Xvivo Perfusion Ab Stock Net Income
| XVIPYDelisted Stock | USD 5.70 0.53 8.51% |
As of the 26th of January, Xvivo Perfusion maintains the Mean Deviation of 2.17, standard deviation of 4.64, and Market Risk Adjusted Performance of 8.82. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Xvivo Perfusion AB, as well as the relationship between them.
Xvivo Perfusion's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Xvivo Perfusion's valuation are provided below:Xvivo Perfusion AB does not presently have any fundamental gauges for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Xvivo |
Search Suggestions
| X | United States Steel | CompanyDelisted |
| XP | Xp Inc | Company |
| XELAP | Exela Technologies Preferred | Company |
| XDFPX | Flaherty Crumrine Dynamic | Mutual Fund |
| XB | BondBloxx ETF Trust | ETF |
| XNG | ARCA Natural Gas | Index |
| XT | XT Token | Cryptocurrency |
| X10001AB5 | ALVGR 32 | Corporate Bond |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Xvivo Perfusion AB reported net income of 8.15 M. This is much higher than that of the sector and significantly higher than that of the Net Income industry. The net income for all United States stocks is notably lower than that of the firm.
Xvivo Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xvivo Perfusion's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Xvivo Perfusion could also be used in its relative valuation, which is a method of valuing Xvivo Perfusion by comparing valuation metrics of similar companies.Xvivo Perfusion is currently under evaluation in net income category among its peers.
Xvivo Fundamentals
| Return On Equity | 0.025 | |||
| Return On Asset | 0.0061 | |||
| Profit Margin | 0.08 % | |||
| Gross Profit | 188.28 M | |||
| Net Income | 8.15 M | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 6.48 X | |||
| Cash Flow From Operations | (12.06 M) | |||
| Number Of Employees | 118 | |||
| Beta | 1.92 |
About Xvivo Perfusion Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xvivo Perfusion AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xvivo Perfusion using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xvivo Perfusion AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Xvivo Pink Sheet
If you are still planning to invest in Xvivo Perfusion AB check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Xvivo Perfusion's history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |